Back to results
US 12,758,529 B2Granted
Use of edaravone in treatment of autism spectrum disorder
AssigneeShanghai Auzone Biological Technology Co., Ltd.
InventorsYi Zhou, Xin Ye
Life of this patent
Estimating the term…
Abstract
The present invention relates to a use of edaravone in the treatment of autism spectrum disorder.
Claims12
A method of treating autism spectrum disorder (ASD), which comprises administering to a subject in need thereof an effective amount of a medicament, which medicament comprises edaravone or a pharmaceutically acceptable salt, analog, or derivative thereof.
Dependencies are inferred from the claim text.